O	0	12	Relationship	Relationship	NN	B-NP
O	13	20	between	between	IN	B-PP
O	21	23	of	of	IN	B-PP
B-Organism_substance	24	29	blood	blood	NN	B-NP
O	30	34	flow	flow	NN	I-NP
O	34	35	,	,	,	O
O	36	43	glucose	glucose	NN	B-NP
O	44	54	metabolism	metabolism	NN	I-NP
O	54	55	,	,	,	O
O	56	63	protein	protein	NN	B-NP
O	64	73	synthesis	synthesis	NN	I-NP
O	73	74	,	,	,	O
O	75	82	glucose	glucose	NN	B-NP
O	83	86	and	and	CC	O
O	87	90	ATP	ATP	NN	B-NP
O	91	98	content	content	NN	I-NP
O	99	101	in	in	IN	B-PP
O	102	116	experimentally	experimentally	RB	B-NP
O	116	117	-	-	HYPH	I-NP
O	117	124	induced	induce	VBN	B-NP
B-Cancer	125	131	glioma	glioma	NN	I-NP
O	132	133	(	(	(	O
B-Cancer	133	136	RG1	RG1	NN	B-NP
I-Cancer	137	138	2	2	CD	I-NP
I-Cancer	138	139	.	.	.	I-NP
I-Cancer	139	140	2	2	CD	I-NP
O	140	141	)	)	)	O
O	142	144	of	of	IN	B-PP
O	145	148	rat	rat	NN	B-NP
B-Organ	149	154	brain	brain	NN	I-NP
O	154	155	.	.	.	O

O	156	158	In	In	IN	B-PP
O	159	171	experimental	experimental	JJ	B-NP
B-Cancer	172	175	RG1	RG1	NN	I-NP
I-Cancer	176	177	2	2	CD	I-NP
I-Cancer	177	178	.	.	.	I-NP
I-Cancer	178	179	2	2	CD	I-NP
I-Cancer	180	186	glioma	glioma	NN	I-NP
O	187	189	of	of	IN	B-PP
O	190	193	rat	rat	NN	B-NP
B-Organ	194	199	brain	brain	NN	I-NP
O	199	200	,	,	,	O
O	201	206	local	local	JJ	B-NP
B-Organism_substance	207	212	blood	blood	NN	I-NP
O	213	217	flow	flow	NN	I-NP
O	217	218	,	,	,	O
O	219	226	glucose	glucose	NN	B-NP
O	227	238	utilization	utilization	NN	I-NP
O	238	239	,	,	,	O
O	240	247	protein	protein	NN	B-NP
O	248	257	synthesis	synthesis	NN	I-NP
O	257	258	,	,	,	O
O	259	266	glucose	glucose	NN	B-NP
O	267	270	and	and	CC	O
O	271	274	ATP	ATP	NN	B-NP
O	275	282	content	content	NN	I-NP
O	283	287	were	be	VBD	B-VP
O	288	296	measured	measure	VBN	I-VP
O	297	299	by	by	IN	B-PP
O	300	305	means	mean	NNS	B-NP
O	306	308	of	of	IN	B-PP
O	309	315	triple	triple	JJ	B-NP
O	316	322	tracer	tracer	NN	I-NP
O	323	338	autoradiography	autoradiography	NN	I-NP
O	339	342	and	and	CC	O
O	343	358	bioluminescence	bioluminescence	NN	B-NP
O	359	368	technique	technique	NN	I-NP
O	368	369	,	,	,	O
O	370	382	respectively	respectively	RB	B-ADVP
O	382	383	,	,	,	O
O	384	386	to	to	TO	B-VP
O	387	396	determine	determine	VB	I-VP
O	397	408	hemodynamic	hemodynamic	JJ	B-NP
O	409	412	and	and	CC	I-NP
O	413	422	metabolic	metabolic	JJ	I-NP
O	423	433	thresholds	threshold	NNS	I-NP
O	434	437	for	for	IN	B-PP
O	438	443	local	local	JJ	B-NP
B-Cancer	444	449	tumor	tumor	NN	I-NP
O	450	456	energy	energy	NN	I-NP
O	457	464	failure	failure	NN	I-NP
O	464	465	.	.	.	O

O	466	475	Perfusion	Perfusion	NN	B-NP
O	476	486	thresholds	threshold	NNS	I-NP
O	487	491	were	be	VBD	B-VP
O	492	501	estimated	estimate	VBN	I-VP
O	502	504	at	at	IN	B-PP
B-Cancer	505	510	tumor	tumor	NN	B-NP
B-Organism_substance	511	516	blood	blood	NN	I-NP
O	517	521	flow	flow	NN	I-NP
O	522	528	values	value	NNS	I-NP
O	529	531	of	of	IN	B-PP
O	532	534	69	69	CD	B-NP
O	534	535	.	.	.	O
O	535	536	0	0	CD	B-NP
O	537	538	+	+	SYM	O
O	538	539	/	/	SYM	O
O	539	540	-	-	SYM	B-NP
O	541	542	0	0	CD	B-NP
O	542	543	.	.	SYM	I-NP
O	543	544	1	1	CD	I-NP
O	545	547	ml	ml	NN	I-NP
O	547	548	/	/	SYM	O
O	548	551	100	100	CD	B-NP
O	552	553	g	g	NN	I-NP
O	553	554	/	/	SYM	B-NP
O	554	557	min	min	NN	B-NP
O	558	559	(	(	(	O
O	559	567	estimate	estimate	NN	B-NP
O	568	569	+	+	SYM	O
O	569	570	/	/	SYM	O
O	570	571	-	-	HYPH	O
O	572	580	standard	standard	JJ	B-NP
O	581	586	error	error	NN	I-NP
O	586	587	)	)	)	O
O	588	591	and	and	CC	O
O	592	594	of	of	IN	B-PP
O	595	597	69	69	CD	B-NP
O	598	599	+	+	SYM	B-NP
O	599	600	/	/	SYM	B-ADVP
O	600	601	-	-	SYM	B-NP
O	602	603	7	7	CD	B-NP
O	603	604	.	.	SYM	I-NP
O	604	605	1	1	CD	I-NP
O	606	608	ml	ml	NN	I-NP
O	608	609	/	/	SYM	O
O	609	612	100	100	CD	B-NP
O	613	614	g	g	NN	I-NP
O	614	615	/	/	SYM	B-NP
O	615	618	min	min	NN	I-NP
O	619	622	for	for	IN	B-PP
O	623	626	the	the	DT	B-NP
O	627	636	beginning	beginning	NN	I-NP
O	637	639	of	of	IN	B-PP
O	640	643	the	the	DT	B-NP
O	644	651	decline	decline	NN	I-NP
O	652	654	in	in	IN	B-PP
O	655	663	regional	regional	JJ	B-NP
O	664	667	ATP	ATP	NN	I-NP
O	668	671	and	and	CC	I-NP
O	672	679	glucose	glucose	NN	I-NP
O	680	687	content	content	NN	I-NP
O	687	688	,	,	,	O
O	689	701	respectively	respectively	RB	B-ADVP
O	701	702	.	.	.	O

O	703	712	Metabolic	Metabolic	JJ	B-NP
O	713	723	thresholds	threshold	NNS	I-NP
O	724	728	were	be	VBD	B-VP
O	729	736	derived	derive	VBN	I-VP
O	737	739	at	at	IN	B-PP
B-Cancer	740	745	tumor	tumor	NN	B-NP
O	746	753	glucose	glucose	NN	I-NP
O	754	765	utilization	utilization	NN	I-NP
O	766	772	values	value	NNS	I-NP
O	773	775	of	of	IN	B-PP
O	776	778	70	70	CD	B-NP
O	778	779	.	.	.	O
O	779	780	6	6	CD	B-NP
O	781	782	+	+	SYM	B-NP
O	782	783	/	/	SYM	I-NP
O	783	784	-	-	SYM	I-NP
O	785	786	8	8	CD	I-NP
O	786	787	.	.	SYM	I-NP
O	787	788	3	3	CD	I-NP
O	789	794	mumol	mumol	NN	I-NP
O	794	795	/	/	SYM	B-NP
O	795	798	100	100	CD	B-NP
O	799	800	g	g	NN	I-NP
O	800	801	/	/	SYM	B-NP
O	801	804	min	min	NN	I-NP
O	805	808	for	for	IN	B-PP
O	809	816	reduced	reduce	VBN	B-NP
O	817	824	protein	protein	NN	I-NP
O	825	834	synthesis	synthesis	NN	I-NP
O	834	835	,	,	,	O
O	836	838	of	of	IN	B-PP
O	839	841	55	55	CD	B-NP
O	841	842	.	.	.	O
O	842	843	0	0	CD	B-NP
O	844	845	+	+	SYM	O
O	845	846	/	/	SYM	O
O	846	847	-	-	SYM	B-NP
O	848	849	0	0	CD	B-NP
O	849	850	.	.	SYM	I-NP
O	850	851	2	2	CD	I-NP
O	852	857	mumol	mumol	NN	I-NP
O	857	858	/	/	SYM	B-NP
O	858	861	100	100	CD	B-NP
O	862	863	g	g	NN	I-NP
O	863	864	/	/	SYM	B-NP
O	864	867	min	min	NN	I-NP
O	868	871	for	for	IN	B-PP
O	872	875	the	the	DT	B-NP
O	876	884	decrease	decrease	NN	I-NP
O	885	887	in	in	IN	B-PP
O	888	895	glucose	glucose	NN	B-NP
O	896	903	content	content	NN	I-NP
O	903	904	,	,	,	O
O	905	908	and	and	CC	O
O	909	911	34	34	CD	B-NP
O	911	912	.	.	.	I-NP
O	912	913	7	7	CD	I-NP
O	914	915	+	+	SYM	O
O	915	916	/	/	SYM	B-NP
O	916	917	-	-	SYM	B-NP
O	918	919	4	4	CD	B-NP
O	919	920	.	.	SYM	I-NP
O	920	921	7	7	CD	I-NP
O	922	927	mumol	mumol	NN	I-NP
O	927	928	/	/	SYM	B-NP
O	928	931	100	100	CD	B-NP
O	932	933	g	g	NN	I-NP
O	933	934	/	/	SYM	B-NP
O	934	937	min	min	NN	I-NP
O	938	941	for	for	IN	B-PP
O	942	949	decline	decline	NN	B-NP
O	950	952	in	in	IN	B-PP
O	953	956	ATP	ATP	NN	B-NP
O	957	964	content	content	NN	I-NP
O	964	965	.	.	.	O

O	966	969	Our	Our	PRP$	B-NP
O	970	977	results	result	NNS	I-NP
O	978	985	suggest	suggest	VBP	B-VP
O	986	990	that	that	IN	B-SBAR
B-Organism_substance	991	996	blood	blood	NN	B-NP
O	997	1001	flow	flow	NN	I-NP
O	1002	1008	limits	limit	VBZ	B-VP
O	1009	1016	glucose	glucose	NN	B-NP
O	1017	1023	supply	supply	NN	I-NP
O	1024	1026	to	to	TO	B-PP
B-Tissue	1027	1032	tumor	tumor	NN	B-NP
I-Tissue	1033	1039	tissue	tissue	NN	I-NP
O	1040	1042	at	at	IN	B-PP
O	1043	1047	much	much	RB	B-NP
O	1048	1054	higher	high	JJR	I-NP
O	1055	1059	flow	flow	NN	I-NP
O	1060	1065	rates	rate	NNS	I-NP
O	1066	1070	than	than	IN	B-PP
O	1071	1073	in	in	IN	B-PP
O	1074	1080	normal	normal	JJ	B-NP
B-Organ	1081	1086	brain	brain	NN	I-NP
O	1087	1092	which	which	WDT	B-NP
O	1092	1093	,	,	,	O
O	1094	1096	in	in	IN	B-PP
O	1097	1101	turn	turn	NN	B-NP
O	1101	1102	,	,	,	O
O	1103	1105	is	be	VBZ	B-VP
O	1106	1116	associated	associate	VBN	I-VP
O	1117	1121	with	with	IN	B-PP
O	1122	1123	a	a	DT	B-NP
O	1124	1132	decrease	decrease	NN	I-NP
O	1133	1135	in	in	IN	B-PP
B-Cancer	1136	1141	tumor	tumor	NN	B-NP
O	1142	1149	glucose	glucose	NN	I-NP
O	1150	1161	utilization	utilization	NN	I-NP
O	1161	1162	.	.	.	O

O	1163	1164	A	A	DT	B-NP
O	1165	1174	reduction	reduction	NN	I-NP
O	1175	1178	and	and	CC	B-NP
O	1179	1182	not	not	RB	I-NP
O	1183	1185	an	an	DT	B-NP
O	1186	1194	increase	increase	NN	I-NP
O	1195	1197	in	in	IN	B-PP
B-Cancer	1198	1203	tumor	tumor	NN	B-NP
O	1204	1211	glucose	glucose	NN	I-NP
O	1212	1224	availability	availability	NN	I-NP
O	1225	1230	could	could	MD	B-VP
O	1231	1233	be	be	VB	I-VP
O	1234	1235	a	a	DT	B-NP
O	1236	1240	more	more	RBR	I-NP
O	1241	1252	appropriate	appropriate	JJ	I-NP
O	1253	1261	strategy	strategy	NN	I-NP
O	1262	1265	for	for	IN	B-PP
O	1266	1269	the	the	DT	B-NP
O	1270	1279	induction	induction	NN	I-NP
O	1280	1282	of	of	IN	B-PP
O	1283	1289	energy	energy	NN	B-NP
O	1290	1297	failure	failure	NN	I-NP
O	1298	1300	in	in	IN	B-PP
B-Cancer	1301	1307	tumors	tumor	NNS	B-NP
O	1307	1308	.	.	.	O

